1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Oh, D.
Shin, S.Y.
Lee, S.
Kim, Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
11855
11864
10.1021/bi000453g
11009597
Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.
2000
10.2210/pdb1f0h/pdb
pdb_00001f0h
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2295.918
CECROPIN A-MAGAININ 2 HYBRID PEPTIDE
A28L
1
syn
polymer
no
yes
KAKLFKKIGIGKFLHSAKKF(NH2)
KAKLFKKIGIGKFLHSAKKFX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-06-14
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_spectrometer.model
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
RCSB
Y
RCSB
2000-05-16
REL
THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE FOR THIS PEPTIDE IS A HYBRID OF SEQUENCES WHICH OCCUR NATURALLY IN HYALOPHORA CECROPIA (CECROPIA MOTH) AND XENOPUS LAEVIS (AFRICAN CLAWED FROG)
sample
structures with the lowest energy
50
20
2D NOESY
4.05
298
K
Distance Geometry-Dynamical Simulated Annealing Hybrid Method
DODECYLPHOSPHOCHOLINE-d38 MICELLES
90% H2O/10% D2O
Brunger, A.T.
refinement
X-PLOR
3.851
400
Bruker
AVANCE
LYS
1
n
1
LYS
1
A
ALA
2
n
2
ALA
2
A
LYS
3
n
3
LYS
3
A
LEU
4
n
4
LEU
4
A
PHE
5
n
5
PHE
5
A
LYS
6
n
6
LYS
6
A
LYS
7
n
7
LYS
7
A
ILE
8
n
8
ILE
8
A
GLY
9
n
9
GLY
9
A
ILE
10
n
10
ILE
10
A
GLY
11
n
11
GLY
11
A
LYS
12
n
12
LYS
12
A
PHE
13
n
13
PHE
13
A
LEU
14
n
14
LEU
14
A
HIS
15
n
15
HIS
15
A
SER
16
n
16
SER
16
A
ALA
17
n
17
ALA
17
A
LYS
18
n
18
LYS
18
A
LYS
19
n
19
LYS
19
A
PHE
20
n
20
PHE
20
A
NH2
21
n
21
NH2
21
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
8
A
A
O
HN1
ALA
NH2
17
21
1.55
1
A
LEU
4
-158.44
20.66
1
A
LYS
6
-143.98
13.64
2
A
LYS
7
-170.11
52.62
3
A
ALA
2
53.48
86.63
3
A
LYS
3
177.22
130.56
3
A
LEU
4
-176.75
43.20
3
A
LYS
6
-153.74
22.23
3
A
LYS
7
-170.41
110.58
4
A
ALA
2
67.87
122.03
4
A
LEU
4
-175.53
29.69
4
A
PHE
5
-61.30
79.77
4
A
LYS
6
-151.35
16.84
4
A
ILE
8
-137.48
-101.09
5
A
ALA
2
-60.82
80.34
5
A
LEU
4
-149.63
48.61
5
A
PHE
5
-64.09
72.53
5
A
LYS
7
-175.56
83.36
6
A
LYS
3
-164.19
53.57
6
A
LEU
4
-152.02
46.10
6
A
LYS
7
-142.95
43.90
7
A
LEU
4
-141.94
37.31
7
A
PHE
5
-57.88
95.59
7
A
LYS
7
-176.95
-172.78
8
A
ALA
2
-179.35
81.83
9
A
PHE
5
-62.60
72.30
9
A
LYS
6
-141.00
10.89
9
A
ILE
8
-127.02
-105.09
10
A
LEU
4
-147.30
36.24
10
A
PHE
5
-101.89
75.99
10
A
LYS
7
-172.23
51.06
11
A
LYS
6
-141.30
15.68
12
A
LYS
3
-169.86
94.38
12
A
LEU
4
-142.66
48.70
12
A
PHE
5
-56.38
103.12
12
A
LYS
6
-140.76
17.40
12
A
ILE
8
-127.19
-79.88
13
A
ALA
2
65.93
63.17
13
A
LEU
4
-147.50
44.13
13
A
PHE
5
-98.16
51.84
14
A
ALA
2
43.82
79.09
14
A
PHE
5
-64.50
68.29
14
A
ILE
8
-126.74
-60.66
15
A
ALA
2
50.20
81.91
15
A
LYS
3
-152.07
89.84
15
A
PHE
5
-98.14
47.00
15
A
ILE
8
-136.22
-102.13
16
A
LEU
4
-161.64
31.69
16
A
PHE
5
-99.51
57.15
16
A
LYS
7
177.79
148.19
16
A
ILE
8
-127.23
-108.40
18
A
ALA
2
54.69
75.32
18
A
LYS
3
-166.89
72.81
18
A
LEU
4
-178.49
52.15
18
A
LYS
7
-178.11
148.76
18
A
ILE
8
-127.90
-105.39
19
A
ILE
8
-126.99
-78.83
20
A
LYS
7
-169.35
91.30
Cecropin A(1-8)-magainin 2(1-12) A2 in dodecylphosphocholine micelles
1
N
N
A
GLY
9
A
GLY
9
HELX_P
A
PHE
20
A
PHE
20
1
1
12
covale
1.305
both
A
PHE
20
A
C
PHE
20
1_555
A
NH2
21
A
N
NH2
21
1_555
ANTIMICROBIAL PROTEIN
Helix, ANTIMICROBIAL PROTEIN
CECA_HYACE
UNP
1
P01507
MAGA_XENLA
UNP
1
P11006
27
34
1F0H
1
8
P01507
A
1
1
8
83
94
1F0H
9
20
P11006
A
2
9
20
1
TRP
engineered mutation
ALA
2
1F0H
A
P01507
UNP
28
2
BINDING SITE FOR RESIDUE NH2 A 21
A
NH2
21
Software
1
A
PHE
20
A
PHE
20
1
1_555
1
P 1